After nearly 15 years of dedicated cultivation, Asclepius Meditec has finally received international recognition from the International Society of Hydrogen Medicine and Biology (ISHMB).
Mr. Lin Hsin-Yung, Founder of Asclepius Meditec, was honored with the Industrial Breakthrough ISHMB Award.
The award ceremony was personally presided over by Professor Shigeo Ohta of Japan, a world-renowned pioneer in hydrogen medicine.
This honor represents not only a high-profile acknowledgment by an internationally authoritative academic society of China's contributions to the field, but also a top-tier endorsement of Asclepius Meditec's "global first-of-its-kind" core capabilities.
It highlights Asclepius Meditec's portfolio of over 500 international invention patents and affirms its leading voice and technological leadership at the forefront of hydrogen-oxygen medicine worldwide.
From November 7 to 9, 2025, the 5th International Society for Hydrogen Medicine and Biology (ISHMB) Conference was grandly held at Juntendo University in Tokyo, Japan. This conference brought together medical experts and scholars from 28 countries and regions, including China, Japan, South Korea, the United States, France, and Russia.
During the award presentation, Mr. Lin Hsin-Yung, Founder of Asclepius Meditec, was presented with the Industrial Breakthrough ISHMB Award. The certificate and trophy were jointly conferred by Professor Shigeo Ohta, Honorary President of the International Society of Hydrogen Medicine and Biology (ISHMB), and Professor Qin Shucun, the incumbent President of the Society.
The certificate of the Industrial Breakthrough ISHMB Award reads: This award is presenting to you in recognition of your pioneering achievement in obtaining medical device approval for a hydrogen gas generator—the first of its kind—and for your remarkable contribution to the advancement and clinical application of hydrogen medicine. Your innovative efforts have opened new frontiers in this emerging scientific field.
Industrial Breakthrough ISHMB Award Trophy
As an emerging discipline, hydrogen medicine has seen three major milestones from basic research to clinical implementation over the past 50 years:
Milestones in the Development of Hydrogen–Oxygen Medicine
In 1975, scholars led by Dole at Baylor University reported in the journal Science on the effects of hydrogen–oxygen mixed gas on cancer [1].
This pioneering work was the first to introduce hydrogen inhalation into the field of disease treatment research, marking the true origin of modern hydrogen–oxygen medicine.
In 2007, Professor Shigeo Ohta, Chief Professor at the Institute of Gerontology, Nippon Medical School, published a paper in the top international journal Nature Medicine, demonstrating that hydrogen gas had significant therapeutic effects in a rat model of cerebral infarction [2]. This discovery attracted global academic attention, officially igniting an explosive wave of research in hydrogen–oxygen medicine and ushering the field into a new era.
In 2020, the nationally innovative hydrogen–oxygen generator developed by Asclepius Meditec successfully passed more than 400 Class III medical device evaluations, including biocompatibility tests, toxicology studies, and electromagnetic compatibility (EMC) testing. It obtained the world's first Class III medical device market authorization for a hydrogen–oxygen generator, and was further approved by the National Medical Products Administration (NMPA) as a Class III active medical device permitted for home-use environments. This groundbreaking achievement enabled hydrogen–oxygen medicine to move beyond theoretical research and enter high-threshold clinical application scenarios, truly advancing the core mission of life sciences for the benefit of humanity.
The emergence of any new frontier in life sciences inevitably involves early academic skepticism and periods of industrial disorder.
Looking back over the past five turbulent years, commercially driven, hastily assembled "products and theories" of questionable rigor have proliferated across artificial intelligence platforms and social media networks. As a result, a highly serious life-science endeavor has become mired in controversy and confusion, leaving 99.9% of global lives deprived of access to scientific truth.
Looking ahead, the critical challenges lie in establishing professional committees for hydrogen–oxygen clinical applications, developing industry standards for related equipment and devices, and scientifically demonstrating the value balance between health insurance and social security systems from the perspective of public health economics.
We call on relevant authorities to strengthen regulatory enforcement, enabling medical professionals, media platforms, the public, and enterprises to operate in compliance with the law—so that humanity may awaken to the health potential of hydrogen–oxygen nutritional medicine (water + organic diet) and ultimately achieve lasting well-being.
